What is the production capacity?

The daily production capacity is 450,000 pieces.

What materials are used for the tubes?

The tubes are made from PET or Glass materials.

Premium EDTA K2 Blood Collection Tube for Laboratory Use

Name: Premium EDTA K2 Blood Collection Tube for Laboratory Use
Brand: Contiwin Co., Ltd
SKU: 2269245355

Shanghai, ChinaContiwin Co., Ltd

US$0.03-0.055

1,000 Pieces

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Type

Drainage Container/Tube

Material

Medical Polymer Materials & Products

Ethylene Oxide Sterilization

Quality Guarantee Period

Two Years

Group

Adult

Logo Printing

Without Logo Printing

Model No.

Gd020ek, Gd030ek, Gd040ek3, Gd050ek, Gd070ek

Tube Material

Pet/Glass

Volume

2ml-10ml

Additive

EDTA K3/K2

Cap Colour

Purple

Transport Package

100PCS/Rack*12racks=1200PCS/CTN

Specification

13*75mm, 13*100mm, 16*100mm

Trademark

OEM ODM

Origin

China

HS Code

90183900

Production Capacity

450000PCS Per Day

Key features

OEM and ODM Services: Over 30 years of experience with own mold factory and 100+ technical engineers.

ISO Certified Factory: ISO13485 and ISO9001 certified with full documentation for registration.

High Production Capacity: Daily output of 450,000 pieces with 300+ injection machines.

Strict Quality Control: 100% inspection during production and random checks before packing.

Fast Sample Delivery: Samples delivered within 3-7 days or 10 days after payment receipt.

Wide Volume Range: Available in 2ml to 10ml volumes with Pet or Glass materials.

Multiple Size Options: Standard sizes include 13*75mm, 13*100mm, and 16*100mm.

Reliable Anticoagulant: Contains EDTA K3/K2 for routine blood examination and hematology tests.

Company profile

Contiwin Co., Ltd

Shanghai, China

Business Type: Manufacturer/FactoryAverage Response Time: ≤0.22h

AI-Powered supplier vetting

SummaryContiwin Co., Ltd is a China-based limited company established in 2020 and identified as a trading company, with an export license and export sales share of 71%–90%. The supplier reports more than 10 production lines, 31–40 quality-control staff, and stated output for hemodialyser flux and A-V blood lines, but other data identifies only three total employees and zero cooperative suppliers, creating internal consistency concerns. Lead times are within 15 workdays in both peak and off-season periods. Overseas infrastructure is limited to participation in an offline medical equipment exhibition; no overseas warehouses, showrooms, agents, branches, or service countries are reported. Quality-system evidence is incomplete: test equipment is listed as zero, complaint procedures and service corrective-action procedures are absent, and quality assurance and traceability status are unknown. No new products, ODM, OEM for popular brands, or SDK are reported. Financial-capacity records are present for multiple years,...

Supplier typeThe supplier is identified as Contiwin Co., Ltd, a China-based limited company established in 2020 and classified as a trading company. Its stated business scope includes medical instruments, production, and import-export services, while no larger-company affiliation is reported.

CertificationsThe supplier explicitly reports holding a valid import and export license. No other certification, quality-system certificate, or product certification is identified in the provided slices, so the assessment is limited to export licensing.

After-Sales capabilityThe supplier reports no written customer-complaint procedures or records, no written service-capability assessment or corrective-action procedures, and no overseas warehouses, showrooms, agents, branches, or service countries. It has participated in one offline medical equipment exhibition and reports lead times within 15 workdays, but these do not establish strong after-sales support.

R&D capabilityThe supplier reports one R&D engineer whose stated responsibility is providing samples to customer requirements. It reports no new products in the past year, no ODM service, no OEM for popular brands, and no available SDK, indicating limited demonstrated innovation capability.